psma-617 and Adenocarcinoma

psma-617 has been researched along with Adenocarcinoma* in 1 studies

Other Studies

1 other study(ies) available for psma-617 and Adenocarcinoma

Article	Year
PSMA-targeted therapy in prostate cancer. Clinical advances in hematology & oncology : H&O, 2021, Volume: 19, Issue:2 Topics: Adenocarcinoma; Antibodies, Bispecific; Antibodies, Neoplasm; Antigens, Surface; Biomarkers, Tumor; Clinical Trials as Topic; Dipeptides; Docetaxel; Glutamate Carboxypeptidase II; Heterocyclic Compounds, 1-Ring; Humans; Immunoconjugates; Immunotherapy, Adoptive; Lutetium; Male; Molecular Targeted Therapy; Nanoparticles; Neoplasm Proteins; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Randomized Controlled Trials as Topic	2021

Article

Year

PSMA-targeted therapy in prostate cancer.

Clinical advances in hematology & oncology : H&O, 2021, Volume: 19, Issue:2

Topics: Adenocarcinoma; Antibodies, Bispecific; Antibodies, Neoplasm; Antigens, Surface; Biomarkers, Tumor; Clinical Trials as Topic; Dipeptides; Docetaxel; Glutamate Carboxypeptidase II; Heterocyclic Compounds, 1-Ring; Humans; Immunoconjugates; Immunotherapy, Adoptive; Lutetium; Male; Molecular Targeted Therapy; Nanoparticles; Neoplasm Proteins; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Randomized Controlled Trials as Topic

2021